The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region

We report the construction of chimeric coxsackievirus B3 (CVB3) strains in which sequences of an infectious cDNA copy of a noncardiovirulent CVB3 genome were replaced by the homologous sequences from a cardiovirulent CVB3 genome to identify which of 10 predicted genetic sites determine cardiovirulence. Cardiovirulent phenotype expression was consistently linked to nucleotide 234 (U in cardiovirulent CVB3 and C in avirulent CVB3) in the 5' nontranslated region. Reconstructions of the parental noncardiovirulent CVB3 genome from chimeras restored the noncardiovirulent phenotype when tested in mice. Inoculation of severe combined immunodeficient (scid) mice with the noncardiovirulent CVB3 strain resulted in massive cardiomyocyte necrosis in all animals. Sequence analysis of viral genomes isolated from twelve scid mouse hearts showed that only nucleotide position 234 was different (a C-->U transition) from that in the input parental noncardiovirulent CVB3 genome. Higher-order RNA structures predicted by two different algorithms did not demonstrate an obvious local effect caused by the C-->U change at nucleotide 234. Initial studies of parental and chimeric CVB3 replication in primary cultures of fetal murine heart fibroblasts and in adult murine cardiac myocytes demonstrated that viral RNA transcriptional efficiency is approximately 10-fold lower for noncardiovirulent CVB3 than for cardiovirulent CVB3. CVB3 did not shut off protein synthesis in murine cardiac fibroblasts, nor were levels of viral protein synthesis significantly different as a function of viral phenotype. Taken together, these data support a significant role for determination of the CVB3 cardiovirulence phenotype by nucleotide 234 in the 5' nontranslated region, possibly via a transcriptional mechanism.

[1]  W. C. Alvarez Enteroviruses , 1958, Gastroenterology.

[2]  R. F. Weaver,et al.  Structure and Regulatory Properties of Eucaryotic RNA Polymerase , 1970 .

[3]  J. Woodruff,et al.  The influence of quantitated post-weaning undernutrition on coxsackievirus B3 infection of adult mice. I. Viral persistence and increased severity of lesions. , 1970, The Journal of infectious diseases.

[4]  C. Gauntt,et al.  Isolation of Coxsackievirus B3 temperture-sensitive mutants and their assignment to complementation groups. , 1977, Biochemical and biophysical research communications.

[5]  R. Kono Enteroviruses other than poliovirus. , 1976, Bulletin of the Pan American Health Organization.

[6]  J. Woodruff,et al.  Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1. , 1977, Journal of immunology.

[7]  D. Baltimore,et al.  Inhibition of translation by poliovirus: inactivation of a specific initiation factor. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Labadie,et al.  Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice , 1979, Journal of medical virology.

[9]  Woodruff Jf Viral myocarditis. A review. , 1980 .

[10]  J. Woodruff Viral myocarditis. A review. , 1980, The American journal of pathology.

[11]  M. Kaplan,et al.  Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. , 1983, Reviews of infectious diseases.

[12]  S. Huber,et al.  Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3 , 1983, Infection and immunity.

[13]  J. Klein,et al.  Infectious Diseases of the Fetus and Newborn Infant , 1983 .

[14]  D. Filman,et al.  Three-dimensional structure of poliovirus at 2.9 A resolution. , 1985, Science.

[15]  N. Chapman,et al.  Coxsackievirus B3: primary structure of the 5' non-coding and capsid protein-coding regions of the genome. , 1985, Virus research.

[16]  John E. Johnson,et al.  Structure of a human common cold virus and functional relationship to other picornaviruses , 1985, Nature.

[17]  J. Maizel,et al.  Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome , 1985, Nature.

[18]  P. Hofschneider,et al.  Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. , 1985, Journal of molecular and cellular cardiology.

[19]  E. Wimmer,et al.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Kameda,et al.  Genetic analysis of the attenuation phenotype of poliovirus type 1 , 1986, Journal of virology.

[21]  B. Semler,et al.  A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Lodge,et al.  Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. , 1987, The American journal of pathology.

[23]  C. Richardson,et al.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  U. Pettersson,et al.  Genome of coxsackievirus B3. , 1987, Virology.

[25]  J. Almond The attenuation of poliovirus neurovirulence. , 1987, Annual review of microbiology.

[26]  R. Kandolf The Impact of Recombinant DNA Technology on the Study of Enterovirus Heart Disease , 1988 .

[27]  V. Agol,et al.  Point mutations modify the response of poliovirus RNA to a translation initiation factor: a comparison of neurovirulent and attenuated strains. , 1988, Virology.

[28]  V. Agol,et al.  Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma , 1989, Journal of virology.

[29]  N. La Monica,et al.  Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y , 1989, Journal of virology.

[30]  M. Uhlén,et al.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. , 1989, Nucleic acids research.

[31]  A. Papavassiliou,et al.  Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Zuker On finding all suboptimal foldings of an RNA molecule. , 1989, Science.

[33]  M. Rossmann The canyon hypothesis. , 1989, Viral immunology.

[34]  M. Skinner,et al.  New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. , 1989, Journal of molecular biology.

[35]  N. Sonenberg,et al.  A cellular protein that binds to the 5'-noncoding region of poliovirus RNA: implications for internal translation initiation. , 1989, Genes & development.

[36]  D. Filman,et al.  Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. , 1989, The EMBO journal.

[37]  K. Leslie,et al.  Clinical and experimental aspects of viral myocarditis , 1989, Clinical Microbiology Reviews.

[38]  A. J. Valente,et al.  Mechanism(S) of Coxsackievirus-Induced Acute Myocarditis in the Mouse , 1989 .

[39]  G. Schild,et al.  Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine , 1989, Journal of virology.

[40]  S. Tracy,et al.  Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s) , 1989, Journal of virology.

[41]  C. Christodoulou,et al.  Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature , 1990, Journal of virology.

[42]  M. Pallansch,et al.  Echovirus 22 is an atypical enterovirus , 1990, Journal of virology.

[43]  R. Kandolf,et al.  Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis , 1990, Journal of virology.

[44]  G. Stanway Structure, function and evolution of picornaviruses. , 1990, The Journal of general virology.

[45]  B. McManus,et al.  A molecular and serologic evaluation of enteroviral involvement in human myocarditis. , 1990, Journal of molecular and cellular cardiology.

[46]  B. McManus,et al.  Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects. , 1990, The American journal of pathology.

[47]  N. Sonenberg Poliovirus translation. , 1990, Current topics in microbiology and immunology.

[48]  Y. Svitkin,et al.  Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U. , 1990, Virology.

[49]  B. McManus,et al.  Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. , 1990, Journal of the American College of Cardiology.

[50]  C. Haisch,et al.  Functional diversity in vascular endothelial cells: role in coxsackievirus tropism , 1990, Journal of virology.

[51]  M. Zuker,et al.  Common structures of the 5' non-coding RNA in enteroviruses and rhinoviruses. Thermodynamical stability and statistical significance. , 1990, Journal of molecular biology.

[52]  W. Thilly,et al.  Optimization of the polymerase chain reaction with regard to fidelity: modified T7, Taq, and vent DNA polymerases. , 1991, PCR methods and applications.

[53]  D. Lynch,et al.  Myocyte Injury and Contraction Abnormalities Produced by Cytotoxic T Lymphocytes , 1991, Circulation.

[54]  B. McManus,et al.  Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. , 1991, European heart journal.

[55]  N. Sonenberg,et al.  In vitro mutational analysis of cis-acting RNA translational elements within the poliovirus type 2 5' untranslated region , 1991, Journal of virology.

[56]  N. Chapman,et al.  Molecular biology and pathogenesis of coxsackie B viruses , 1991 .

[57]  B. Semler,et al.  Poliovirus translation initiation: differential effects of directed and selected mutations in the 5' noncoding region of viral RNAs. , 1991, Virology.

[58]  E. Wimmer,et al.  Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5' nontranslated region and involvement of a cellular 57-kilodalton protein , 1991, Journal of virology.

[59]  R. Ren,et al.  Identification of two determinants that attenuate vaccine-related type 2 poliovirus , 1991, Journal of virology.

[60]  V. Agol,et al.  The 5′-Untranslated Region of Picornaviral Genomes , 1991, Advances in Virus Research.

[61]  S. Le,et al.  Structural and functional analysis of the ribosome landing pad of poliovirus type 2: in vivo translation studies , 1991, Journal of virology.

[62]  D. Stone,et al.  Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. , 1992, Virology.

[63]  U. Pettersson,et al.  Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. , 1992, Virus research.

[64]  B. Semler,et al.  Conservation of RNA-protein interactions among picornaviruses , 1992, Journal of virology.

[65]  E. Ehrenfeld,et al.  Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5' noncoding region , 1992, Journal of virology.

[66]  S. Le,et al.  Conserved tertiary structure elements in the 5′ untranslated region of human enteroviruses and rhinoviruses , 1992, Virology.

[67]  K. Klingel,et al.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[68]  B. McManus,et al.  Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[69]  N. Chapman,et al.  Interesting problems in enteroviral inflammatory heart disease. , 1992, Herz.

[70]  M. Hoffman,et al.  Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation , 1992, Journal of virology.

[71]  R. Kandolf,et al.  Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5′‐nontranslated region does not contain major attenuation determinants , 1993, Journal of medical virology.

[72]  P. Sarnow,et al.  Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification , 1993, Journal of virology.

[73]  E. Wimmer,et al.  A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Rueckert,et al.  WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14 , 1993, Journal of virology.

[75]  R. Andino,et al.  Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′‐end of viral RNA. , 1993, The EMBO journal.

[76]  M. Sole,et al.  Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. , 1993, Journal of the American College of Cardiology.

[77]  E. Wimmer,et al.  Genetics of poliovirus. , 1993, Annual review of genetics.

[78]  K. Klingel,et al.  The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains. , 1993, Scandinavian journal of infectious diseases. Supplementum.

[79]  J. G. Patton,et al.  The involvement of a spliceosome component in internal initiation of human rhinovirus RNA translation. , 1993, The Journal of general virology.

[80]  A. Ramsingh,et al.  Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype , 1993, Journal of virology.

[81]  N. Bowles,et al.  Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. , 1994, Circulation.

[82]  T. Martino,et al.  Viral infection and the pathogenesis of dilated cardiomyopathy. , 1994, Circulation research.

[83]  R. Gutell,et al.  Lessons from an evolving rRNA: 16S and 23S rRNA structures from a comparative perspective. , 1994, Microbiological reviews.

[84]  E. Wimmer,et al.  The cellular polypeptide p57 (pyrimidine tract-binding protein) binds to multiple sites in the poliovirus 5' nontranslated region , 1994, Journal of virology.

[85]  K. Kean,et al.  Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis. , 1994, The EMBO journal.

[86]  M. Herzum,et al.  Coxsackievirus B3 infection leads to cell death of cardiac myocytes. , 1994, Journal of molecular and cellular cardiology.

[87]  J. Towbin,et al.  Acute Myocarditis : Rapid Diagnosis by PCR in Children 331 TABLE 1 . Dallas Criteria * General definition : Myocardial cell injury with degeneration or necrosis with inflammatory infiltrate not due to ischemia , 2005 .

[88]  P. Keeling,et al.  A prospective case-control study of antibodies to coxsackie B virus in idiopathic dilated cardiomyopathy. , 1994, Journal of the American College of Cardiology.

[89]  V. Agol,et al.  Internal translation initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro , 1994, Journal of virology.

[90]  H. Müller-Hermelink,et al.  Persistence of virus and viral genome in myocardium after Coxsackievirus B3‐induced murine myocarditis , 1994, Clinical and experimental immunology.